Have a personal or library account? Click to login
Solubility enhancement of atorvastatin by embedding in micro sized carrier Cover

Solubility enhancement of atorvastatin by embedding in micro sized carrier

Open Access
|Feb 2020

References

  1. 1. Panghal D, Nagpal M, Thakur GS, Arora S. Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique. Scientia pharmaceutica. 2013;82(1):177-91.10.3797/scipharm.1301-23395122824634850
  2. 2. Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin singel doses: relevance of first pass effect from hepatic uptake transposrtes, and intestinal and hepatic metabolism. Drug Metabolism and Disposition. 2006;34(7):1175-81.10.1124/dmd.105.00907616624870
  3. 3. Prabhu P, Patravale V. Dissolution enhancement of atorvastatin calcium by co-grinding technique. Drug delivery and translational research. 2016;6(4):380-91.
  4. 4. Rodde MS, Divase GT, Devkar TB, Tekade AR. Solubility and Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin: In Vitro, Ex Vivo, and In Vivo Studies. BioMed Research International. 2014;2014:10.10.1155/2014/463895406568024995297
  5. 5. Han L, Li M, Liu Y, Han C, Ye P. Atorvastatin May Delay Cardiac Aging by Upregulating Peroxisome Proliferator-Activated Receptors in Rats. Pharmacology. 2012;89(1-2):74-82.10.1159/00033578322343316
  6. 6. Ahmed IS, El Hosary R, Hassan MA, Haider M, Abd-Rabo MM. Efficacy and Safety Profiles of Oral Atorvastatin-Loaded Nanoparticles: Effect of Size Modulation on Biodistribution. Molecular pharmaceutics. 2018;15(1):247-55.10.1021/acs.molpharmaceut.7b0085629232954
  7. 7. Chen Z-g, Cai H-j, Jin X, Lu J-h, Wang J, Fang N-y. Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: A 1-year randomized trial. Archives of Gerontology and Geriatrics. 2014;59(3):515-21.10.1016/j.archger.2014.07.00625131773
  8. 8. McGown CC, Brookes ZLS, Hellewell PG, Ross JJ, Brown NJ. Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2015;388(5):557-64.10.1007/s00210-015-1100-y25678054
  9. 9. Ahmed IS, El-Hosary R, Shalaby S, Abd-Rabo MM, Elkhateeb DG, Nour S. PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-epsilon-caprolactone nanoparticles. International journal of pharmaceutics. 2016;504(1-2):70-9.10.1016/j.ijpharm.2016.03.04527021467
  10. 10. Yao GT, Song LP, Xue WH, Su GH, Ning AH, Wang J. Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium. Saudi journal of biological sciences. 2018;25(6):1016-21.10.1016/j.sjbs.2017.03.015611743530174496
  11. 11. Mathur M, Devi Vemula K. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia. Drug development and industrial pharmacy. 2018;44(12):2048-60.10.1080/03639045.2018.150822530073852
  12. 12. Thenmozhi S, Dharmaraj N, Kadirvelu K, Kim HY. Electrospun nanofibers: New generation materials for advanced applications. Materials Science and Engineering: B. 2017;217:36-48.10.1016/j.mseb.2017.01.001
  13. 13. Xue J, Xie J, Liu W, Xia Y. Electrospun Nanofibers: New Concepts, Materials, and Applications. Accounts of Chemical Research. 2017;50(8):1976-87.10.1021/acs.accounts.7b00218658909428777535
  14. 14. Ignatious F, Sun L, Lee C-P, Baldoni J. Electrospun Nanofibers in Oral Drug Delivery. Pharmaceutical Research. 2010;27(4):576-88.10.1007/s11095-010-0061-620143253
  15. 15. Cozza ES, Monticelli O, Marsano E, Cebe P. On the elect-rospinning of PVDF: influence of the experimental conditions on the nanofiber properties. Polymer International. 2013;62(1):41-8.10.1002/pi.4314
  16. 16. Desai S, Disouza J, Sable A, Hosmani A. Development of Orodispersible Tablet of Atorvastatin Calcium Using Hot Melt Extrusion. Drug Delivery Letters. 2015;5(1):19-30.10.2174/2210303104666141029233757
  17. 17. Székely-szentmiklósi B, Hancu G, Székely-szentmiklósi I, Kovács B, Kelemen H. Simultaneous determination of atorvastatin and ezetimibe from combined pharmaceutical products by micellar electrokinetic capillary chromatography. Brazilian Journal of Pharmaceutical sciences. 2017;53(1):e16122.10.1590/s2175-97902017000116122
  18. 18. Shete G, Puri V, Kumar L, Bansal A. Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. AAPS PharmSciTech. 2010;11(2):588-609.10.1208/s12249-010-9419-7290231920352531
DOI: https://doi.org/10.2478/orvtudert-2019-0004 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 47 - 52
Submitted on: Feb 28, 2019
Accepted on: Apr 2, 2019
Published on: Feb 13, 2020
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 Rédai Emőke, Zsombori Mónika, Székely-Szentmiklósi Blanka, Sipos Emese, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.